Melodiol Global Health Ltd. (COPHF)

[AddyStone]

Latest news $COPHF - Increased revenue growth

Creso Pharma achieves second consecutive quarter of record
revenue growth

Creso Group revenue growth:

• Total revenue generated during the quarter ended 30 June 2021 (Q2 CY2021) of
A$1,715,933 – a 24% increase on the previous quarter (Q1 CY2021: A$1,385,000)
• Q2 CY2021 revenue marks a 451% increase on the previous corresponding period (Q2
CY2020: A$311,353)
• Strong sales growth witnessed through Swiss operations and wholly-owned Canadian
subsidiary Mernova Medical Inc.
• Multiple purchase orders (“PO”) from various provinces highlight increased demand for
Mernova’s products in Canada and scalable recurring revenue model
• Creso has a positive outlook on sales growth, with potential Red Light Holland (“RLH”)
merger providing multiple new near term market entries and scale up opportunities
• Sales growth represents the second quarter of consecutive record revenue for the Creso
Pharma Group
• Ongoing growth demonstrates Company’s strategy to create consistent revenue
generation across all business divisions

https://clients3.weblink.com.au/pdf/CPH/02390527.pdf